DEVELOPMENT AND VALIDATION OF A NEW PREDICTION TOOL TO ASSESS IMMINENT HIP FRACTURE RISK IN PATIENTS STARTING ORAL BISPHOSPHONATES: A REAL WORLD COHORT STUDY INCLUDING 373, 455 PARTICIPANTS FROM DENMARK, SPAIN AND THE UK